Piotr Wnuk, Author at - Page 12 of 14

Big pharma bosses, along with around 150 other business leaders, are facing a serious public relations question ignited

To go or not to go, that’s a Trump question

https://pharmaphorum.com/news/trump-question-uk-visit/

News/ News/ R&D

Study indicates potential breakthrough HIV drug

Piotr Wnuk Abivax, HIV, HIV/AIDS, infectious diseases 0 Comment

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant

Study indicates potential breakthrough HIV drug

https://pharmaphorum.com/news/study-indicates-breakthrough-hiv/

News/ News/ R&D

Review finds medical benefits of cannabis-based drugs

Piotr Wnuk cannabinoid, cannabis, Epidolex, GW Pharma 0 Comment

The use of medical cannabis in the UK has moved a step closer, after the home secretary asked

Review finds medical benefits of cannabis-based drugs

https://pharmaphorum.com/news/review-finds-medical-benefits-cannabis-drugs/

Market Access/ News/ News

Amazon is absolutely serious about disrupting healthcare

Piotr Wnuk Amazon, M&A, pharmacy 0 Comment

After months of speculation around how Amazon will enter the healthcare market, the home delivery giant announced the

Amazon is absolutely serious about disrupting healthcare

https://pharmaphorum.com/news/amazon-is-serious-about-disrupting-healthcare/

health care icon pattern medical innovation concept background design

Digital/ Views & Analysis/ Views and analysis

Four steps to building an innovation culture in pharma

Piotr Wnuk digital, digital innovation, Innoplexus, Lawrence Ganti 0 Comment

The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in

Four steps to building an innovation culture in pharma

https://pharmaphorum.com/views-and-analysis/four-steps-to-building-an-innovation-culture-in-pharma/

News/ Pfizer/ Top pharmaceutical companies/ Top stories

Pfizer increases prices in the US for the second time this year

Piotr Wnuk Donald Trump, Pfizer, pricing 0 Comment

The largest standalone drug maker in the US, announced it increase the prices of around 100 drugs for

Pfizer increases prices in the US for the second time this year

https://pharmaphorum.com/news/pfizer-increases-prices-us-second-time/

Digital/ News/ News/ News/ Patients

NHS app to end scramble for GP appointments

Piotr Wnuk digital health innovation, digital health solutions, NHS, NHS Digital, NHS digitisation 0 Comment

App is ‘world first’ according to health secretary

NHS app to end scramble for GP appointments

https://pharmaphorum.com/news/nhs-new-app-empowers-patients/

Market Access/ News/ News/ News/ R&D

AstraZeneca cancer drugs approved in Japan

Piotr Wnuk Astra Zeneca, cancer, Imfinzi, Japan, Lynparza 0 Comment

AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months

AstraZeneca cancer drugs approved in Japan

https://pharmaphorum.com/r-d/astrazenecas-cancer-drugs-approved-japan/

News/ News/ Novartis/ R&D

Lilly joins CGRP race to cure migraine

Piotr Wnuk Amgen, Botox, Eli Lilly, Emgality, Erenumab, migraine, Novartis 0 Comment

Eli Lilly are gearing up to announce details from the latest Emgality analysis, which can potentially push the

Lilly joins CGRP race to cure migraine

https://pharmaphorum.com/news/lilly-joins-cgrp-race-to-cure-migraine/

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

To go or not to go, that’s a Trump question

Study indicates potential breakthrough HIV drug

Review finds medical benefits of cannabis-based drugs

Amazon is absolutely serious about disrupting healthcare

Four steps to building an innovation culture in pharma

Pfizer increases prices in the US for the second time this year

NHS app to end scramble for GP appointments

AstraZeneca cancer drugs approved in Japan

Lilly joins CGRP race to cure migraine

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

Login